Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Romeo

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Opinion in Rheumatology|March 20, 2021
Recent advances in the treatment of neuromyelitis optica spectrum disordersAndrew R Romeo
The Neurohospitalist|October 5, 2017
Bithalamic Inflammation in Relapsing-Remitting Multiple SclerosisAndrew R Romeo, Maulik Shah
Current Opinion in Rheumatology|March 29, 2019
Treatment of neuromyelitis optica spectrum disordersAndrew R Romeo, Benjamin M Segal
Neurology. Clinical Practice|June 24, 2022
SARS-CoV-2 Infection and Vaccination Outcomes in Multiple SclerosisJenna A Brunn, Galit Levi Dunietz, Andrew R Romeo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 28, 2021
Validation of an obstructive sleep apnea symptom inventory in persons with multiple sclerosisMini Singh, Ronald Gavidia, Galit Levi Dunietz, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 23, 2018
A young man with numbness in arms and legs: From the National Multiple Sclerosis Society Case Conference ProceedingsAndrew R Romeo, Robert P Lisak, Ethan Meltzer, et al.
JAMA Network Open|March 16, 2019
Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple SclerosisValerie J Block, Riley Bove, Chao Zhao, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 25, 2020
An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosisAndrew R Romeo, William M Rowles, Erica S Schleimer, et al.
The Lancet. Neurology|October 18, 2024
Comparative effectiveness of cognitive behavioural therapy, modafinil, and their combination for treating fatigue in multiple sclerosis (COMBO-MS): a randomised, statistician-blinded, parallel-arm trialTiffany J Braley, Dawn M Ehde, Kevin N Alschuler, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 30, 2022
Remote Observational Research for Multiple Sclerosis: A Natural ExperimentRiley Bove, Shane Poole, Richard Cuneo, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Rheumatology|March 20, 2021
Recent advances in the treatment of neuromyelitis optica spectrum disordersAndrew R Romeo
The Neurohospitalist|October 5, 2017
Bithalamic Inflammation in Relapsing-Remitting Multiple SclerosisAndrew R Romeo, Maulik Shah
Current Opinion in Rheumatology|March 29, 2019
Treatment of neuromyelitis optica spectrum disordersAndrew R Romeo, Benjamin M Segal
Neurology. Clinical Practice|June 24, 2022
SARS-CoV-2 Infection and Vaccination Outcomes in Multiple SclerosisJenna A Brunn, Galit Levi Dunietz, Andrew R Romeo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 28, 2021
Validation of an obstructive sleep apnea symptom inventory in persons with multiple sclerosisMini Singh, Ronald Gavidia, Galit Levi Dunietz, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 23, 2018
A young man with numbness in arms and legs: From the National Multiple Sclerosis Society Case Conference ProceedingsAndrew R Romeo, Robert P Lisak, Ethan Meltzer, et al.
JAMA Network Open|March 16, 2019
Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple SclerosisValerie J Block, Riley Bove, Chao Zhao, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 25, 2020
An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosisAndrew R Romeo, William M Rowles, Erica S Schleimer, et al.
The Lancet. Neurology|October 18, 2024
Comparative effectiveness of cognitive behavioural therapy, modafinil, and their combination for treating fatigue in multiple sclerosis (COMBO-MS): a randomised, statistician-blinded, parallel-arm trialTiffany J Braley, Dawn M Ehde, Kevin N Alschuler, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 30, 2022
Remote Observational Research for Multiple Sclerosis: A Natural ExperimentRiley Bove, Shane Poole, Richard Cuneo, et al.
Pageof 2